[ET Net News Agency, 24 April 2025] HANSOH PHARMA (03692) rose 3.2% to HK$24.5.
It hits an intra-day high of HK$24.5, and an intra-day low of HK$23.7. The total shares traded was 1.23 million, with a value of HK$29.5m. The active buy/sell ratio is 70:30, with net buying turnover of HK$10.58m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive buying turnover of HK$1.54m, with volume weighted average price of HK$24.081. CHINA INNOVATION MARKET SER accounts for greatest net responsive selling turnover of HK$3.22m, with volume weighted average price of HK$24.183. The stock has risen a combined 12.1% over the past 4 consecutive trading days.
The Hang Seng Index now rose 1 point, or less than 0.1% to 22,074.
Basic Information| Nominal | 24.500 | % Chg | +3.16% |
| High | 24.500 | Low | 23.700 |
| Shares Tr | 1.23m | Turnover | 29.5m |
| 10-D SMA | 22.710 | %H.V | 69.285 |
| 20-D SMA | 22.705 | VWAP | 24.066 |
| 50-D SMA | 20.404 | RSI14 | 65.668 |
Status: Active buy/sell ratio is 70:30, with net buying turnover of HK$10.58m, rising a combined 12.1% over the past 4 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 24.50 | +3.16 |
| SIHUAN PHARM (00460) | 0.65 | Unchanged |
| GRAND PHARMA (00512) | 6.02 | +0.33 |
| SINO BIOPHARM (01177) | 3.91 | +1.82 |
| LIVZON PHARMA (01513) | 27.00 | +0.75 |
| LUYE PHARMA (02186) | 2.03 | +1.50 |
| FOSUN PHARMA (02196) | 14.96 | +2.19 |
| SH PHARMA (02607) | 10.82 | -0.18 |
| JACOBSON PHARMA (02633) | 1.21 | -0.82 |
| CHINARES PHARMA (03320) | 4.98 | +0.20 |
(ed)
